Home/Filings/4/0001209191-23-035463
4//SEC Filing

Seth Alpna 4

Accession 0001209191-23-035463

CIK 0001664710other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:47 PM ET

Size

5.4 KB

Accession

0001209191-23-035463

Insider Transaction Report

Form 4
Period: 2023-06-06
Seth Alpna
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-06+10,00010,000 total
    Exercise: $48.79Exp: 2033-06-05Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001721020

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:47 PM ET
Size
5.4 KB